<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="7720">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00895843</url>
  </required_header>
  <id_info>
    <org_study_id>9938</org_study_id>
    <nct_id>NCT00895843</nct_id>
  </id_info>
  <brief_title>Protective Analgesia for Postoperative Pain Relief Following Day Case Oral Surgery</brief_title>
  <official_title>Protective Analgesia Using Bupivacaine and Conventional Release Ibuprofen Versus Bupivacaine and Sustained Release Ibuprofen for Postoperative Pain Relief in Patients Undergoing Third Molar Surgery: a Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manchester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Central Manchester University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Manchester</source>
  <oversight_info>
    <authority>United Kingdom: Medicines and Healthcare Products Regulatory Agency</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether robust analgesic regime (protective
      analgesia) can improve postoperative pain experience for patients undergoing lower wisdom
      teeth extraction under day case general anaesthetic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study was to demonstrate and improve postoperative pain experience using
      protective analgesia for patients undergoing oral surgery under day case general
      anaesthesia.

      The primary objective was to investigate the efficiency of protective analgesia using
      combined effects of sustained release ibuprofen and bupivacaine nerve block in attenuation
      of postoperative pain following impacted third molar surgery under day case general
      anaesthesia.

      The secondary objective was to document the safety and tolerability profile of conventional
      release versus sustained released ibuprofen with bupivacaine block in subjects undergoing
      impacted third molar surgery under day case general anaesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Number of Patients Needing Rescue Medication</measure>
    <time_frame>At 6 hours</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Pain Intensity</measure>
    <time_frame>30 mins, 1 hour, 6 hours, 24 hours and 48 hours after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Rescue</measure>
    <time_frame>Between 30mins and 48 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Control/Relief</measure>
    <time_frame>48 hours after surgery (end of study)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">122</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Wisdom Tooth</condition>
  <arm_group>
    <arm_group_label>Conventional ibuprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Brufen retard</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Brufen retard</intervention_name>
    <description>Single dose 2 x 800mg tablets 2 hours prior to surgery</description>
    <arm_group_label>Brufen retard</arm_group_label>
    <other_name>sustained release ibuprofen</other_name>
    <other_name>modified release ibuprofen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ibuprofen</intervention_name>
    <description>Single dose ibuprofen 2 x 200mg tablets 2 hours prior to surgery</description>
    <arm_group_label>Conventional ibuprofen</arm_group_label>
    <other_name>Brufen</other_name>
    <other_name>neurofen</other_name>
    <other_name>conventional release ibuprofen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Up to 10ml of Bupivacaine 0.5% with 1:200,000 Adrenaline given prior to surgical incision as inferior alveolar nerve block and long buccal nerve infiltration.</description>
    <arm_group_label>Conventional ibuprofen</arm_group_label>
    <arm_group_label>Brufen retard</arm_group_label>
    <other_name>Marcain 0.5% with 1 in 200,000 epinephrine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy male and female patients aged 18 years and over

          -  patients requiring removal of one or more third molars, with at lease one completely
             or partially impacted in the mandible needing bone removal

        Exclusion Criteria:

          -  history of allergy to NSAIDs

          -  pregnant

          -  history of GI disease

          -  history of bleeding disorders

          -  alcohol dependancy

          -  drug abuse
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Coulthard, BDS FDS PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manchester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Manchester and Manchester Children's NHS University Hospitals</name>
      <address>
        <city>Manchester</city>
        <state>Lancashire</state>
        <zip>M13 9PL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Manchester NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <state>Lancashire</state>
        <zip>M13 9PL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <lastchanged_date>May 7, 2009</lastchanged_date>
  <firstreceived_date>March 24, 2009</firstreceived_date>
  <firstreceived_results_date>March 24, 2009</firstreceived_results_date>
  <responsible_party>
    <name_title>Professor Paul Coulthard</name_title>
    <organization>University of Manchester</organization>
  </responsible_party>
  <keyword>Third molar</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Conventional Ibuprofen</title>
        </group>
        <group group_id="P2">
          <title>Brufen Retard</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Conventional Ibuprofen</title>
        </group>
        <group group_id="B2">
          <title>Brufen Retard</title>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="60"/>
                <measurement group_id="B2" value="62"/>
                <measurement group_id="B3" value="122"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0.0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="60"/>
                <measurement group_id="B2" value="62"/>
                <measurement group_id="B3" value="122.0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0.0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="28.71" spread="5.809"/>
                <measurement group_id="B2" value="28.82" spread="6.262"/>
                <measurement group_id="B3" value="28.77" spread="6.013"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="40"/>
                <measurement group_id="B2" value="16"/>
                <measurement group_id="B3" value="56.0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
                <measurement group_id="B2" value="46"/>
                <measurement group_id="B3" value="66.0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United Kingdom</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="60"/>
                <measurement group_id="B2" value="62"/>
                <measurement group_id="B3" value="122.0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients Needing Rescue Medication</title>
        <description>Number of patients who required rescue medication within 6 hours</description>
        <time_frame>At 6 hours</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Conventional Ibuprofen</title>
          </group>
          <group group_id="O2">
            <title>Brufen Retard</title>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="48"/>
                  <measurement group_id="O2" value="50"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Number of Patients Needing Rescue Medication</title>
            <description>Number of patients who required rescue medication within 6 hours</description>
            <units>Participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="32"/>
                  <measurement group_id="O2" value="29"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Pain Intensity</title>
        <description>Mean VAS scores of pain intensity for each time points</description>
        <time_frame>30 mins, 1 hour, 6 hours, 24 hours and 48 hours after surgery</time_frame>
        <safety_issue>No</safety_issue>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Rescue</title>
        <description>Time taken for rescue medication requirement</description>
        <time_frame>Between 30mins and 48 hours</time_frame>
        <safety_issue>No</safety_issue>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Control/Relief</title>
        <description>Patient satisfaction scores</description>
        <time_frame>48 hours after surgery (end of study)</time_frame>
        <safety_issue>No</safety_issue>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Conventional Ibuprofen</title>
        </group>
        <group group_id="E2">
          <title>Brufen Retard</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1"/>
                <counts group_id="E2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1"/>
                <counts group_id="E2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Mr Sin L Yong</name_or_title>
      <organization>University of Manchester</organization>
      <phone>01612756806</phone>
      <email>sin.l.yong@manchester.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
